Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients

@inproceedings{Caocci2011EthicalIO,
  title={Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients},
  author={Giovanni Caocci and Giorgio La Nasa and Ernesto D'aloja and Adriana Vacca and Eugenia Piras and Michela Pintor and Roberto Demontis and Salvatore Pisu},
  booktitle={BMC medical ethics},
  year={2011}
}
BACKGROUND Beta thalassemia major is a severe inherited form of hemolytic anemia that results from ineffective erythropoiesis. Allogenic hematopoietic stem cell transplantation (HSCT) remains the only potentially curative therapy. Unfortunately, the subgroup of adult thalassemia patients with hepatomegaly, portal fibrosis and a history of irregular iron chelation have an elevated risk for transplantation-related mortality that is currently estimated to be about 29 percent. DISCUSSION… CONTINUE READING
5 Citations
29 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Decision making in adult thalassemia patient undergoing unrelated bone marrow transplantation: quality of life, communication factors and ethical issues. Bone Marrow Transplantation

  • G Caocci
  • 2006
1 Excerpt

Quality of Life in Thalassemia

  • P Telfer
  • Annals of the New York Academy of Science
  • 2005
1 Excerpt

Rachmilewitz E: Beta-thalassemia

  • D Rund
  • New England Journal of Medicine
  • 2005
1 Excerpt

Unrelated donor bone marrow transplantation in adult patients with thalassemia. Bone Marrow Transplantation

  • G La Nasa
  • 2005
1 Excerpt

Similar Papers

Loading similar papers…